Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma

Detalles Bibliográficos
Autores principales: Ma, Heng, Feng, Peng-Hui, Yu, Shuang-ni, Lu, Zhao-Hui, Yu, Qi, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153199/
https://www.ncbi.nlm.nih.gov/pubmed/35637429
http://dx.doi.org/10.1186/s12885-022-09692-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153199/
https://www.ncbi.nlm.nih.gov/pubmed/35637429
http://dx.doi.org/10.1186/s12885-022-09692-0

Ejemplares similares